WO2022217325A1 - Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique - Google Patents
Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique Download PDFInfo
- Publication number
- WO2022217325A1 WO2022217325A1 PCT/BR2021/050152 BR2021050152W WO2022217325A1 WO 2022217325 A1 WO2022217325 A1 WO 2022217325A1 BR 2021050152 W BR2021050152 W BR 2021050152W WO 2022217325 A1 WO2022217325 A1 WO 2022217325A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic composition
- aluminum
- composition
- antiperspirant
- antiperspirant cosmetic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 157
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 89
- 230000001166 anti-perspirative effect Effects 0.000 title claims abstract description 78
- 239000002537 cosmetic Substances 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 15
- 230000008569 process Effects 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 239000003974 emollient agent Substances 0.000 claims abstract description 32
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 27
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 210000004243 sweat Anatomy 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims description 25
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 21
- 239000000194 fatty acid Substances 0.000 claims description 21
- 229930195729 fatty acid Natural products 0.000 claims description 21
- 239000004094 surface-active agent Substances 0.000 claims description 21
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 18
- HAMGNFFXQJOFRZ-UHFFFAOYSA-L aluminum;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4] HAMGNFFXQJOFRZ-UHFFFAOYSA-L 0.000 claims description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- -1 alkyl glucoside Chemical class 0.000 claims description 15
- 239000001993 wax Substances 0.000 claims description 14
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 claims description 13
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 claims description 13
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 12
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 claims description 11
- 229940031578 diisopropyl adipate Drugs 0.000 claims description 11
- 239000000839 emulsion Substances 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 9
- 229960004889 salicylic acid Drugs 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229940048506 aluminum zirconium tetrachlorohydrex gly Drugs 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 150000003873 salicylate salts Chemical class 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 7
- YCLAMANSVUJYPT-UHFFFAOYSA-L aluminum chloride hydroxide hydrate Chemical compound O.[OH-].[Al+3].[Cl-] YCLAMANSVUJYPT-UHFFFAOYSA-L 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 229940074928 isopropyl myristate Drugs 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229940053431 aluminum sesquichlorohydrate Drugs 0.000 claims description 6
- 229940031569 diisopropyl sebacate Drugs 0.000 claims description 6
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 claims description 6
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 6
- 229940075495 isopropyl palmitate Drugs 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 5
- XILPPDQAWPSZIL-UHFFFAOYSA-H dialuminum;dichloride;tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-] XILPPDQAWPSZIL-UHFFFAOYSA-H 0.000 claims description 5
- 229930182478 glucoside Natural products 0.000 claims description 5
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000003381 solubilizing effect Effects 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 3
- 239000011874 heated mixture Substances 0.000 claims description 2
- 238000007711 solidification Methods 0.000 claims description 2
- 230000008023 solidification Effects 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- ZYYRAHJUNAIHTP-UHFFFAOYSA-A dialuminum;zirconium(4+);heptachloride;heptahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Zr+4].[Zr+4] ZYYRAHJUNAIHTP-UHFFFAOYSA-A 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 35
- 229920001983 poloxamer Polymers 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 13
- 150000002148 esters Chemical class 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 12
- 230000007928 solubilization Effects 0.000 description 12
- 238000005063 solubilization Methods 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 10
- 239000004698 Polyethylene Substances 0.000 description 9
- 239000013543 active substance Substances 0.000 description 8
- WYANSMZYIOPJFV-UHFFFAOYSA-L aluminum;2-aminoacetic acid;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4].NCC(O)=O WYANSMZYIOPJFV-UHFFFAOYSA-L 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229920000223 polyglycerol Polymers 0.000 description 7
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 7
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 239000002781 deodorant agent Substances 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- ADGFKRMKSIAMAI-UHFFFAOYSA-L oxygen(2-);zirconium(4+);chloride;hydroxide Chemical compound [OH-].[O-2].[Cl-].[Zr+4] ADGFKRMKSIAMAI-UHFFFAOYSA-L 0.000 description 3
- 229960000502 poloxamer Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003892 tartrate salts Chemical class 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 2
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- YXZZLAMCXFHTTE-UHFFFAOYSA-N aluminum;propane-1,2-diol;trihypochlorite;hydrate Chemical compound O.[Al+3].Cl[O-].Cl[O-].Cl[O-].CC(O)CO YXZZLAMCXFHTTE-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 150000005691 triesters Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- FDGMRBVRSRWANY-UHFFFAOYSA-N C(CCCCCCC)(=O)C1=CC=C(C(C(=O)O)=C1)O.C(C=1C(O)=CC=CC1)(=O)O Chemical compound C(CCCCCCC)(=O)C1=CC=C(C(C(=O)O)=C1)O.C(C=1C(O)=CC=CC1)(=O)O FDGMRBVRSRWANY-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- HDIFHQMREAYYJW-XGXNLDPDSA-N Glyceryl Ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(O)CO HDIFHQMREAYYJW-XGXNLDPDSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 229920002507 Poloxamer 124 Polymers 0.000 description 1
- 229920002511 Poloxamer 237 Polymers 0.000 description 1
- 229920002517 Poloxamer 338 Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- SJXYSRSHDPPYIU-UHFFFAOYSA-L aluminum;propane-1,2-diol;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].CC(O)CO SJXYSRSHDPPYIU-UHFFFAOYSA-L 0.000 description 1
- YPPRKFXMPDSDJV-UHFFFAOYSA-J aluminum;sodium;2-hydroxypropanoate Chemical compound [Na+].[Al+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O YPPRKFXMPDSDJV-UHFFFAOYSA-J 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- KNXDJTLIRRQLBE-UHFFFAOYSA-H dialuminum;propane-1,2-diol;chloride;pentahydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].CC(O)CO KNXDJTLIRRQLBE-UHFFFAOYSA-H 0.000 description 1
- BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 229940116338 glyceryl ricinoleate Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 229940093448 poloxamer 124 Drugs 0.000 description 1
- 229940116406 poloxamer 184 Drugs 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 229920001521 polyalkylene glycol ether Polymers 0.000 description 1
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Definitions
- ANTIPERSPIRANT COSMETIC COMPOSITIONS USE OF THE ANTIPERSPIRANT COSMETIC COMPOSITION, AND PROCESS FOR MANUFACTURING AN ANTIPERPIRANT COSMETIC COMPOSITION
- the present invention is directed to an antiperspirant cosmetic composition which combines exfoliant peeling agents, emollients, and aluminum salts to achieve a stable antiperspirant cosmetic composition that provides sweat and unpleasant odor protection. Additionally, the present invention is directed to the use of an antiperspirant cosmetic composition and process for manufacturing an antiperspirant cosmetic composition.
- Sweating though a natural bodily function, results in the formation of wet patches on human skin and/or clothing. Moreover, the sweat secreted from sweat glands has a tendency to form a malodorous due to its interaction with the many microorganisms which reside on the skin surface, particularly the skin of the underarm. These two phenomena are deemed to be undesirable for consumers.
- Antiperspirant products possess ingredients which inhibit/suppress sweating, whereas deodorant products possess ingredients that mask the malodors caused by sweat. Many products address both phenomena simultaneously.
- Antiperspirant active agents generally consist of salts or complexes of aluminum and/or zirconium, such as aluminum chloride and aluminum hydroxy halides. These substances help to reduce the flow of sweat.
- antiperspirant products are available in the market, such as powders, liquids, gels, emulsions, soft solids and sticks.
- antiperspirant active agents To achieve a satisfactory antiperspirant effect, it is needed to use high concentrations of antiperspirant active agents. Such high concentration of antiperspirant active agents affects the stabilization of the cosmetic composition in view of the interaction with the other ingredients, as well as can cause irritation to the skin.
- Such stabilization of antiperspirant cosmetic composition is also impacted when the composition comprises exfoliant peeling agents such as salicylic acid derivatives.
- exfoliant peeling agents such as salicylic acid derivatives.
- Such compounds occur in crystalline form and are not soluble in water or in oils traditionally used in the cosmetic field. Consequently, they tend to remain crystalline within various compositions, which significantly reduces the bioavailability of the compound and the cosmetic composition.
- the presence of crystalline salicylic acid derivatives provides formulations which are unstable due, for example, to settling, and which are unpleasant regarding texture and appearance from consumer’s viewpoint.
- Document CA2138110 discloses to solubilization of salicylic acid derivatives in vegetable oils, like flowers and fruit oils, using a process that involves the rising of temperature to achieve the solubilization.
- those oils are complex mixtures of many different classes of compounds, and it may impact on the stability and the cost of formulas.
- such document uses a different process to solubilize the salicylic acid derivatives (hot process).
- the present invention aims to provide a stable antiperspirant cosmetic composition combining exfoliant peeling agent, emollients, and aluminum salts that provides protection against sweat and malodors while maintaining the physical stability of the composition and having properly cosmeticity and sensoriality for cosmetics/antiperspirants applications.
- the invention achieves the desired antiperspirant effect in the presence of high concentration of aluminum salts, exfoliant peeling agent and emollients, while maintaining the physical stability, which was achieved by the specific raw materials and concentration ranges.
- the antiperspirant cosmetic composition of the present invention is alcohol-free.
- the antiperspirant cosmetic composition of the present invention provides good sensorial, good spreadability, less thickness, brightness, refreshing properties, hydration, and softness to the skin.
- the present invention is directed to an antiperspirant cosmetic composition
- an antiperspirant cosmetic composition comprising exfoliant peeling agent, emollients, and antiperspirant agents.
- Such antiperspirant cosmetic composition is stable over the time (physical stability), providing protection against sweat and malodors, and also have achieved good consumer perceiving such as good sensorial, good spreadability, less thickness, brightness, refreshing properties, hydration and softness to the skin.
- the present invention is directed to the use of an antiperspirant cosmetic composition and process for manufacturing an antiperspirant cosmetic composition.
- the antiperspirant cosmetic composition of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations of the present invention described herein, as well as any of the additional or optional ingredients, components, or limitations described herein.
- hydrophilic actives means ingredients that are water-soluble.
- the expression “at least one” means one or more and thus includes individual components as well as mixtures/combinations.
- Figure 1 illustrates the scale of solubilization in mass of capryloyl salicylic acid/mass of emollient and has the purpose to find a limit of solubilization by the visual aspect.
- Figure 2 illustrates the scale of solubilization in mass of capryloyl salicylic acid/mass of emollient and has the purpose to find a limit of solubilization by the visual aspect (upper view).
- Figure 3 illustrates the particularity of the emollient of the invention for the solubilization of the active.
- emollients for antiperspirant purposes like dimethicone, are not able to provide the availability to the exfoliant peeling agent (capryloyl salicylic acid) in the selected proportion.
- the antiperspirant cosmetic composition of the present invention comprises:
- exfoliant peeling agent selected from capryloyl salicylic acid, salicylic acid, salicylates, lactic acid, and mixtures thereof;
- emollient selected from fatty acid isopropyl esters, chosen from isopropyl myristate, diisopropyl adipate, isopropyl palmitate, diisopropyl sebacate, and mixtures thereof; and
- the exfoliant peeling agent of the composition of the present invention is in a range of from about 0.15% to about 2%, preferably from about 0.1% to about 1%, based on the total weight of the composition.
- the emollient of the antiperspirant cosmetic composition of the present invention is in a range of from about 3.5% to about 27%, preferably from about 6% to about 25%, based on the total weight of the composition.
- the antiperspirant agent of the antiperspirant cosmetic composition of the present invention is selected from aluminum chlorohydrate, aluminum zirconium tetrachlorohydrex gly, aluminum sesquichlorohydrate, aluminum zirconium pentachlorohydrate, aluminum dichlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrate, and mixtures thereof.
- the antiperspirant agent of the antiperspirant cosmetic composition of the present invention is in a range of from about 10% to about 45% and more preferably from about 12% to about 38%, based on the total weight of the composition.
- the antiperspirant cosmetic composition of the present invention further comprises surfactant and water (emulsion format), or wax (anhydrous stick format).
- the surfactant(s) is(are) selected from C -22 alcohols (and) C12-20 alkyl glucoside.
- the surfactant is present in a range of from about 2% to about 10%, preferably from about 3% to about 8%, more preferably from about 4% to about 6%, based on the total weight of the composition.
- the wax is selected from hydrogenated castor oil.
- the wax is in range of from about 2% to about 6% by weight, preferably from about 2.5 % to about 5%, based on the total weight of the composition.
- the antiperspirant cosmetic composition may be in the form of lotions, milks, creams, gels, gel creams, foams, roll-on, sprays, and sticks.
- the antiperspirant cosmetic composition of the invention can be used as a daily product for the skin.
- the antiperspirant cosmetic composition is in emulsion formats (W/O) (such as roll-on format), or anhydrous stick formats.
- W/O emulsion formats
- anhydrous stick formats such as roll-on format
- the antiperspirant cosmetic composition of the present invention has a pH of from about 3.5 to about 5.0, preferably from about 4.0 to about 4.5.
- the present invention is related to the use of the antiperspirant cosmetic composition for manufacturing a product for reducing, masking or absorbing human malodorous.
- An example of suitable antiperspirant cosmetic composition according to the present invention comprises:
- emollient selected from isopropyl myristate, diisopropyl adipate, and mixtures thereof;
- antiperspirant agent(s) selected from aluminum salts, selected from aluminum chlorohydrate, aluminum zirconium tetrachlorohydrex gly, aluminum sesquichlorohydrate, aluminum zirconium pentachlorohydrate, aluminum dichlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium trichlorohydrate, and mixtures thereof; wherein the amounts are based on the total weight of the composition.
- the antiperspirant cosmetic composition of the present invention further comprises surfactant and water, or wax.
- the surfactant is selected from Cu-22 alcohols (and) C12-20 alkyl glucoside.
- the surfactant is present in a range of 2% to 10% based on the total weight of the composition.
- the wax according to the antiperspirant cosmetic composition of the present invention is selected from hydrogenated castor oil.
- the wax is in range of 2% to 6% by weight, based on the total weight of the composition.
- antiperspirant cosmetic composition comprises: (a) from about 0.15% to about 2% of capryloyl salicylic acid;
- emollient selected from isopropyl myristate, diisopropyl adipate, and mixtures thereof;
- antiperspirant agent(s) selected from aluminum salts, such as aluminum chlorohydrate, aluminum zirconium tetrachlorohydrex gly, and mixtures thereof; all the amounts mentioned above are based on the total weight of the composition.
- the antiperspirant cosmetic composition of the present invention further comprises surfactant and water, or wax.
- the surfactant is selected from Cu-22 alcohols (and) C12-20 alkyl glucoside.
- the surfactant is present in range of 3% to 8% based on the total weight of the composition.
- the wax according to the antiperspirant cosmetic composition of the present invention is selected from hydrogenated castor oil.
- the wax is in range of 2.5% to 5% by weight, based on the total weight of the composition.
- the antiperspirant cosmetic composition of the present invention may further comprise deodorant active agents.
- Preferred deodorant active agents may be selected from zinc PCA, zinc gluconate, triethyl citrate and mixtures thereof.
- the deodorant active agent is in a range of from about 0.1% to about 5%, preferably about 0.5% to about 3%, and more preferably from about 1% to 2%, relative to the total weight of the composition.
- exfoliant peeling agents according to the present invention include salicylic acid, salicylates, lactic acid, and mixtures thereof.
- the degree of peeling/exfoliation will depend on the amount of peeling ingredient.
- the antiperspirant cosmetic composition of the present invention comprises capryloyl salicylic acid, which is a derivative (ester) of salicylic acid (2-hydroxy-5-octanoyl benzoic acid), known as lipohydroxy acid (LHA).
- capryloyl salicylic acid which is a derivative (ester) of salicylic acid (2-hydroxy-5-octanoyl benzoic acid), known as lipohydroxy acid (LHA).
- capryloyl derivative has exfoliating and soothing properties, as well as documented improvement in skin tone, wrinkles, and clogged pores. Additionally, capryloyl salicylic acid has many cosmetic functions such as an anti-aging and anti-acne active.
- such ingredient is more lipophilic or fat-dissolving, allowing a gentle exfoliation by weakening bonds between the cells of the surface layer of the stratum corneum. It also possesses astringent properties that further enable better skin protection.
- the exfoliant peeling agent of the composition of the present invention is in a range of from about 0.1% to about 3%, preferably from about 0.15% to about 2%, preferably from about 0.1% to about 1%, based on the total weight of the composition.
- the antiperspirant cosmetic composition according to the present invention comprises emollient(s) selected from fatty acid isopropyl esters, chosen from isopropyl myristate, diisopropyl adipate, isopropyl palmitate, diisopropyl sebacate, and mixtures thereof.
- emollient(s) of the antiperspirant cosmetic composition of the present invention are vehicle to solubilize the exfoliant peeling agent and provide properly cosmeticity and sensoriality for cosmetics/antiperspirants applications.
- the composition of the present invention may comprises cetearyl octanoate, hexyl laurate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, octanoates, decanoates or ricinoleates of alcohols or polyalcohols, such as propylene glycol dioctanoate; hydroxylated esters, such as isostearyl lactate or diisostearyl malate; and pentaerythritol esters; citrates or tartrates, such as di(linear C12-C13 alkyl) tartrates, and also di(linear C14-C15 alkyl) tartrates, or acetates; or mixtures of synthetic esters.
- alcohols or polyalcohols such as propylene glycol dioctanoate
- hydroxylated esters such as isostearyl lactate or diisostearyl malate
- the emollient of the antiperspirant cosmetic composition of the present invention is in a range of from about 3% to 35%, preferably from about 3.5% to about 27%, preferably from about 6% to about 25%, based on the total weight of the composition.
- antiperspirant ingredient means any substance capable of reducing the flow of sweat.
- the antiperspirant ingredients which can be used according to the invention are preferably chosen from aluminum salts, such as aluminum chlorohydrate, aluminum zirconium tetrachlorohydrex gly, and mixtures thereof.
- aluminum salts such as aluminum chlorohydrate, aluminum zirconium tetrachlorohydrex gly, and mixtures thereof.
- Other examples are the zirconium salts, complexes of zirconium chlorohydrate and of aluminum chlorohydrate with an amino acid, and mixtures thereof.
- Non-limiting examples of aluminum salts useful in the invention include, for example, aluminum chlorohydrate in the activated or nonactivated form, aluminum chlorohydrex, the aluminum chlorohydrex polyethylene glycol complex, the aluminum chlorohydrex propylene glycol complex, aluminum dichlorohydrate, the aluminum dichlorohydrex polyethylene glycol complex, the aluminum dichlorohydrex propylene glycol complex, aluminum sesquichlorohydrate, the aluminum sesquichlorohydrex polyethylene glycol complex, the aluminum sesquichlorohydrex propylene glycol complex, aluminum sulphate buffered by sodium aluminum lactate, and mixtures thereof.
- Non-limiting examples of complexes of zirconium chlorohydrate and aluminum chlorohydrate with an amino include, for example, aluminum zirconium octachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium trichlorohydrate, and mixtures thereof.
- ZAG zirconium chlorohydrate and of aluminum chlorohydrate with an amino acid
- ZAG when the amino acid is glycine
- the ZAG complexes usually exhibit an Al/Zr quotient ranging from about 1 .67 to 12.5 and a Metal/Cl quotient ranging from about 0.73 to 1.93.
- Non-limiting examples of these complexes include, for example, aluminum zirconium octachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium tetrachloro-hydrex glycine aluminum zirconium trichlorohydrex glycine complexes, and mixtures thereof.
- the antiperspirant ingredient is aluminum chlorohydrate, in particular the product sold by SummitReheis under the name REACH 103, aluminum sesquichlorohydrate, in particular the product sold by SummitReheis under the name REACH 301 , aluminum zirconium tetrachlorohydrex GLY (INCI name), in particular the product sold by SummitReheis under the name REACH AZP-908, and mixtures thereof.
- Aluminum Zirconium Tetrachlorohydrex GLY can be combined with a maximum of 5% of aluminum chlorohydrate.
- the antiperspirant ingredients are preferably present in the composition according to the invention in a range of from about 5% to about 50%, preferably from about 10% to about 45%, preferably from about 12% to about 38%, based on the total weight of the composition.
- the antiperspirant cosmetic composition of the present invention may further comprises additional surfactants such as alkyl- and polyalkyl- esters of glycerol, polyglycerol ester of fatty acids, mixtures of alkyl- and polyalkyl- esters of glycerol with polyglyceryl, such as polyglyceryl-3 methylglucose distearate, oxyalkylenated (more particularly polyoxyethylenated), fatty acid esters of glycerol; oxyalkylenated fatty acid esters of sorbitan; oxyalkylenated (oxyethylenated and oxypropylenated) fatty acid esters; oxyalkylenated (oxyethylenated and oxypropylenated) fatty alcohol ethers; sugar esters, for instance sucrose stearate; fatty alcohol ethers of sugars, especially alkyl polyglucosides (APG)
- Oxyalkylenated (oxyethylenated and oxypropylenated) fatty alcohol ethers are preferably those having a number of ethylene or propylene oxide (EO/PO) units ranging from 2 to 200. Mention may be made to steareth 40, steareth 100, beheneth 40 and beheneth 100.
- Alkyl- esters of glycerol includes glyceryl esters of fatty acids, such as glyceryl stearate (glyceryl mono-, di-, and tristearate), glyceryl laurate or glyceryl ricinoleate, and mixtures thereof.
- polyoxyalkylenated derivatives thereof mono-, di-, or triester of fatty acids with a polyoxyalkylenated glycerol (mono, di-, or triester of fatty acids with a polyalkylene glycol ether of glycerol) can be cited, preferably polyoxyethylenated glyceryl stearate (mono-, di-, and tristearate), such as PEG-20 glyceryl stearate (mono-, di-, and tristearate).
- Polyglycerol esters of fatty acids may be selected from the group consisting of esters derived from the reaction of polyglycerol having from 2 to 12 glycerol units, preferably from 3 to 10 glycerol units and of at least one fatty acid 20 comprising from 8 to 24 carbon atoms, preferably from 8 to 20 carbon atoms, preferably from 10 to 18 carbon atoms and more preferably 10 to 14 carbon atoms.
- Fatty acids containing from 8 to 24 carbon atoms may be linear or branched, saturated or unsaturated.
- the fatty acids may be selected from the group consisting of oleic acid, stearic acid, isostearic acid, lauric acid, palmitic acid, myristic acid, linoleic acid, capric acid, caprylic acid, and mixtures thereof.
- polyglycerol esters of fatty acid are selected from esters derived from the reaction of polyglycerol comprising 2 to 12 glycerol units, preferably from 4 to 10 glycerol units, and of at least a fatty acid having less than 16 carbon atoms, preferably less than 15 carbon atoms, for example from 8 to 16 carbon atoms and better still from 8 to 14 carbon atoms.
- the polyglycerol ester of fatty acid is selected from the group consisting of polyglycerol esters derived from the reaction comprising 4 to 10 glycerol units and of at least one fatty acid comprising from 8 to 12 carbon atoms preferably 10 to 12 carbon atoms such as lauric acid and / or capric acid.
- ester from polyglyceryl-10 reaction glycerol homopolymer comprising 10 glycerol units
- lauric acid ICI name: polyglyceryl- 10 laurate
- ester from the reaction polyglycerol-4 glycerol 5 homopolymer comprising 4 glycerol units
- capric acid ICI name: polyglyceryl-4 caprate
- nonionic surfactants to be used in the surfactant system of the present invention include polycondensates of ethylene oxide and of propylene oxide of the structure below: H-(0-CH2-CH2)a-(0-CH(CH 3 )-CH2)b-(0-CH2-CH2)a-0H, in which a, a’ range from 2 to 150, and b ranges from 1 to 100.
- a and a’ range from 10 to 130 and b ranges from 20 to 80, better still a and a’ range from 50 to 130 and b ranges from 30 to 80, and even better still a and a’ range from 80 to 130 and b ranges from 40 to 80.
- a and a’ are identical.
- the polycondensate of ethylene oxide and propylene oxide that is useful in the composition of the invention preferably has a weight-average molecular weight ranging from 250 to 19 000, better still ranging from 1200 to 15 000, in particular ranging from 1500 to 10000 and even better still ranging from 1500 to 5000.
- Synperonic® PE/F32 (INCI name: Poloxamer 108), Synperonic® PE/F108 (INCI name: Poloxamer 338), Synperonic® PE/L44 (INCI name: Poloxamer 124), Synperonic® PE/L42 (INCI name: Poloxamer 122), Synperonic® PE/F127 (INCI name: Poloxamer 407), Synperonic® PE/F88 (INCI name: Poloxamer 238), Synperonic® PE/L64 (INCI name: Poloxamer 184), Synperonic® PE/F88 (INCI name: Poloxamer 238), Synperonic® PE/F87 (INCI name: Poloxamer 237) by the company Croda, or Lu
- Preferred surfactants may be selected from cetearyl alcohol, stearyl alcohol, cetyl alcohol or benehyl alcohol, and a mixture thereof.
- the amount of the additional surfactants may range from about 2% to about 20%, relative to the total weight of the composition.
- composition of the invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from perfumes/fragrances, preserving agents, antioxidants, solvents, additional actives agents, vitamins, polymers, deodorant active agents, thickening agents, fatty compounds, oils, waxes, fillers, surfactants, whitening agents/active compounds and mixtures thereof.
- any usual cosmetically acceptable ingredient which may be chosen especially from perfumes/fragrances, preserving agents, antioxidants, solvents, additional actives agents, vitamins, polymers, deodorant active agents, thickening agents, fatty compounds, oils, waxes, fillers, surfactants, whitening agents/active compounds and mixtures thereof.
- Additional ingredients may represent from about 0.1% to 30%, by weight of the total weight of the composition of the invention.
- step (iii) in the vessel of step (ii), adding the remaining oil phase/ingredients and the product of step (i) and heating until 75°C;
- step (ii) heating the solubilized exfoliant peeling agent of step (i) with the oil phase, wax(s), fatty compounds until 65 °C;
- compositions of the present invention are Examples 1 to 3 and
- Comparative Compositions are Examples 4 and 5
- a screening test was carried out with emollients in order to evaluate solubilization of the exfoliant peeling agent.
- 1g of exfoliant peeling agent was mixed with 46g of the emollient in room temperature using Speed Mixer (a mixing equipment that uses centrifuge force) for 3 minutes, 3500 rpm.
- the aspect of the mixtures was analyzed, looking for suspended or decanted particles and a comparison with the pure emollient was made.
- the samples were also submitted into a stress test at 4 °C for one week to observe if the recrystallization will occur.
- This protocol was executed with the emollients: dimethicone, ethylhexyl palmitate, isononyl isononanoate, caprylic/capric triglyceride, dicaprylyl ether, PEG-6, dicaprylyl carbonate, glyceryl isostearate, isopropyl myristate, diisopropyl adipate, and octyldodecanol.
- Figure 3 illustrates the solubilization test of isopropyl myristate (invention) and dimethicone (comparative).
- Ex. 1 and Ex. 2 show a better stability and homogeneous aspect when compared with Ex. 4 and Ex. 5.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2021/050152 WO2022217325A1 (fr) | 2021-04-14 | 2021-04-14 | Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique |
BR112023014061A BR112023014061A2 (pt) | 2021-04-14 | 2021-04-14 | Composições cosméticas antitranspirantes, uso e processos de fabricação de uma composição cosmética antitranspirante |
FR2107451A FR3121843B1 (fr) | 2021-04-14 | 2021-07-09 | Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante, et processus de fabrication d’une composition cosmétique anti-transpirante |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2021/050152 WO2022217325A1 (fr) | 2021-04-14 | 2021-04-14 | Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022217325A1 true WO2022217325A1 (fr) | 2022-10-20 |
Family
ID=75746087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2021/050152 WO2022217325A1 (fr) | 2021-04-14 | 2021-04-14 | Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique |
Country Status (3)
Country | Link |
---|---|
BR (1) | BR112023014061A2 (fr) |
FR (1) | FR3121843B1 (fr) |
WO (1) | WO2022217325A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3792068A (en) | 1971-04-02 | 1974-02-12 | Procter & Gamble | Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation |
WO1989002264A1 (fr) * | 1987-09-15 | 1989-03-23 | Claus Riemann & Co. Aps | Composition antitranspiration |
CA2138110A1 (fr) | 1994-01-10 | 1995-07-11 | Jacqueline Griat | Composition cosmetique et/ou dermatologique contenant des derives d'acide salicylique et procede de solubilisation de ces derives |
US6159479A (en) | 1997-09-16 | 2000-12-12 | L'oreal | Hydrous salicylic acid solutions |
US20170172894A1 (en) * | 2015-12-17 | 2017-06-22 | Henkel Ag & Co. Kgaa | Propellant-free deodorants and/or antiperspirants comprising at least two different preservatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3255082A (en) * | 1962-04-16 | 1966-06-07 | Procter & Gamble | Method of preparing stable aluminum chlorhydrate-alkali metal- and alkaline earth metal salt complex antiperspirant stick |
FR3023475B1 (fr) * | 2014-07-09 | 2016-07-22 | Oreal | Composition cosmetique ou dermatologique solide anhydre a base de particules a liberation d'agent benefique |
DE102015225958A1 (de) * | 2015-12-18 | 2017-06-22 | Henkel Ag & Co. Kgaa | Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen |
-
2021
- 2021-04-14 BR BR112023014061A patent/BR112023014061A2/pt unknown
- 2021-04-14 WO PCT/BR2021/050152 patent/WO2022217325A1/fr active Application Filing
- 2021-07-09 FR FR2107451A patent/FR3121843B1/fr active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3792068A (en) | 1971-04-02 | 1974-02-12 | Procter & Gamble | Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation |
WO1989002264A1 (fr) * | 1987-09-15 | 1989-03-23 | Claus Riemann & Co. Aps | Composition antitranspiration |
CA2138110A1 (fr) | 1994-01-10 | 1995-07-11 | Jacqueline Griat | Composition cosmetique et/ou dermatologique contenant des derives d'acide salicylique et procede de solubilisation de ces derives |
US6159479A (en) | 1997-09-16 | 2000-12-12 | L'oreal | Hydrous salicylic acid solutions |
US20170172894A1 (en) * | 2015-12-17 | 2017-06-22 | Henkel Ag & Co. Kgaa | Propellant-free deodorants and/or antiperspirants comprising at least two different preservatives |
Also Published As
Publication number | Publication date |
---|---|
BR112023014061A2 (pt) | 2023-11-21 |
FR3121843B1 (fr) | 2024-03-01 |
FR3121843A1 (fr) | 2022-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2149366B1 (fr) | Composition anti-transpirante/déodorante | |
AU2006315119B2 (en) | Antiperspirant compositions | |
EP2516017B1 (fr) | Procédé de fabrication d'une composition antitranspirante liquide anhydre | |
EP1814505B1 (fr) | Procede cosmetiques pour les aisselles | |
EP2999452B2 (fr) | Compositions anti-transpirantes | |
EP2999454A1 (fr) | Compositions antitranspirantes | |
US8883130B2 (en) | Transparent antiperspirant gels | |
JP2001523699A (ja) | 発汗抑制または防臭組成物 | |
US9867765B2 (en) | Antiperspirant compositions | |
CA3018257C (fr) | Stick antitranspirant sous forme d'emulsion huile dans l'eau | |
EP2854747B1 (fr) | Composition cosmétique comprenant la combinaison d'un dérivé lipophile d'acide salicylique, d'un sel ou d'un complexe d'aluminium antitranspirant et d'un sel d'acide (acide aminé)-n,n-diacétique | |
WO2021016683A1 (fr) | Composition antitranspirante et désodorisante anhydre, son procédé de production et son utilisation | |
WO2022217325A1 (fr) | Compositions cosmétiques anti-transpirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique | |
KR20030074401A (ko) | 액상 화장료 | |
WO2022178598A1 (fr) | Compositions cosmétiques en bâton, utilisation de la composition cosmétique en bâton et procédé de fabrication de la composition cosmétique en bâton | |
EP3493786B1 (fr) | Actif et methode correspondante pour reduire les mauvaises odeurs | |
US20230338246A1 (en) | Antiperspirant stick compositions | |
WO2022178600A1 (fr) | Compositions cosmétiques antitranspirantes, utilisation de la composition cosmétique anti-transpirante et procédé de fabrication d'une composition cosmétique | |
EP2642974B1 (fr) | Procédé de traitement de la transpiration utilisant un composé de carbonyle capable de réagir via la réaction de maillard | |
JP2007099649A (ja) | 化粧料組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21722365 Country of ref document: EP Kind code of ref document: A1 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112023014061 Country of ref document: BR |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: 112023014061 Country of ref document: BR Free format text: APRESENTAR ESCLARECIMENTOS A RESPEITO DE DIVERGENCIA NOS NOMES DOS TITULARES DO PEDIDO NA FASE NACIONAL, EM RELACAO A PUBLICACAO WO/2022/217325, UMA VEZ QUE CONSTAM DOIS DEPOSITANTES NA FASE INTERNACIONAL. |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01Y Ref document number: 112023014061 Country of ref document: BR Kind code of ref document: A2 Free format text: ANULADA A PUBLICACAO CODIGO 1.5 NA RPI NO 2756 DE 31/10/2023 POR TER SIDO INDEVIDA. |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 112023014061 Country of ref document: BR Kind code of ref document: A2 Effective date: 20230713 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21722365 Country of ref document: EP Kind code of ref document: A1 |